Inhibrx Biosciences OverviewInhibrx Biosciences Research & Development
Research & Development expenses for INBX.
Quarterly R&D Expenses
$24.69M
↓ 33.06% YoY
As of Mar 31, 2026
Annual R&D Expenses (TTM)
$100.84M
↓ 42.83% YoY
Trailing 12 months ending Mar 31, 2026